NCT04568863 Efficacy of Intravenous Melatonin on Mortality in Adult Patients Admitted to the Intensive Care Unit With COVID-19 Status COMPLETED Phase PHASE2
NCT04568499 Presenting Nutrition Characteristics, Comorbidities and Outcomes of COVID-19 in African Humanitarian Settings Status COMPLETED Phase N/A
NCT04568044 Evaluation of Humoral Immunity Following COVID-19 in Pregnancy Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04568031 Study of AZD1222 for the Prevention of COVID-19 in Japan Status COMPLETED Phase PHASE1/PHASE2
NCT04566770 A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Status COMPLETED Phase PHASE2
NCT04565080 Clinical Correlates of COVID-19 Pandemic in Patients With Functional Movement Disorder (FMD) and Parkinson's Disease (PD) Status COMPLETED Phase N/A
NCT04565067 Identification and Characterization of SARS-CoV-2 Specific CD8 T Cells in Humans Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04564287 An Observational Study of Neurologic Function After COVID-19 Infection Status COMPLETED Phase N/A
NCT04564040 A Study in Healthy Subjects to Assess Bioavailability (Proportion of a Drug Which Enters the Circulation to Have an Active Effect) of Acalabrutinib Tablet and Protonpump Inhibitor Effect (Members of a Class of Medications That Inhibits in Gastric Acid Production) for Rabeprazole Status COMPLETED Phase PHASE1
NCT04561193 Investigation of Subsequent and Co-infections Associated With SARS-CoV-2 (COVID-19) Status COMPLETED Phase N/A
NCT04555005 Mindfulness-based Crisis Intervention for COVID-19 Frontline Healthcare Workers During COVID-19 Status COMPLETED Phase NA
NCT04552951 Effect of Vitamin D on Morbidity and Mortality of the COVID-19 Status UNKNOWN Phase PHASE4
NCT04552366 A Clinical Trial of a Recombinant Adenovirus 5 Vectored COVID-19 Vaccine (Ad5-nCoV) With Two Doses in Healthy Adults Status COMPLETED Phase PHASE1
NCT04551911 Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19 Status COMPLETED Phase PHASE2
NCT04551547 Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19 Status COMPLETED Phase PHASE1/PHASE2
NCT04550338 Antiviral Effects of TXA as a Preventative Treatment Following COVID-19 Exposure Status WITHDRAWN Phase PHASE3